详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Synthesis and biological evaluation of 1, 2, 4-oxadiazole derivatives as novel GPR119 agonists.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School of Sichuan University, Chengdu, China [2]Division of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China

出处：

DOI：

ISSN：

关键词： agonistic activity cAMP GPCR GPR119 SAR study

摘要：

A series of 1, 2, 4-oxadiazole derivatives have been designed and synthesized, and 25 compounds were evaluated their abilities by the assay of cAMP concentration in GPR119-transfected HEK293T cells. All compounds showed acceptable agonistic effects on GPR119. Among these compounds, 4p exhibited the best agonistic effects with the EC50 of 20.6 nm, which was comparable to that of positive control GPR119 agonist GSK1292263. The agonistic activity of these 1,2,4-oxadiazole derivatives led to the establishment of a structure-activity relationship. © 2016 John Wiley & Sons A/S.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 3 区医学

小类 | 3 区药物化学 4 区生化与分子生物学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区生化与分子生物学 4 区药物化学

第一作者：

第一作者机构： [1]State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School of Sichuan University, Chengdu, China

通讯作者：

通讯机构： [1]State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School of Sichuan University, Chengdu, China [2]Division of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China [*1]State Key Laboratory of Biotherapy and Kidney Research Institute, West China Hospital, West China Medical School of Sichuan University, Chengdu, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Synthesis and biological evaluation of 1, 2, 4-oxadiazole derivatives as novel GPR119 agonists. [2]Discovery and SAR Study of Quinoxaline-Arylfuran Derivatives as a New Class of Antitumor Agents [3]Design, synthesis, and biological evaluation of quinazoline derivatives as dual HDAC1 and HDAC6 inhibitors for the treatment of cancer. [4]SAR Study and Molecular Mechanism Investigation of Novel Naphthoquinone-furan-2-cyanoacryloyl Hybrids with Antitumor Activity [5]Cryo-EM reveals cholesterol binding in the lysosomal GPCR-like protein LYCHOS [6]The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects [7]GPCR-mediated natural products and compounds: Potential therapeutic targets for the treatment of neurological diseases [8]Development of novel phenoxy-diketopiperazine-type plinabulin derivatives as potent antimicrotubule agents based on the co-crystal structure. [9]Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug [10]Synthesis, SAR study, and bioactivity evaluation of a series of Quinoline-Indole-Schiff base derivatives: Compound 10E as a new Nur77 exporter and autophagic death inducer.